SHARES NEWS & ANALYSIS
- blur Group PLC (1)
- Vernalis PLC (1)
- Unitech Corporate Parks PLC (1)
- Stanley Gibbons Group Ltd (1)
- SkyePharma PLC (1)
- Sinclair IS Pharma PLC (1)
- Silence Therapeutics PLC (1)
- Scapa Group PLC (1)
- Retroscreen Virology Group PLC (1)
- Regenersis PLC (1)
- Pharmaceuticals & Biotechnology (8)
- Oil & Gas (2)
- Software & Computer Services (2)
- Banks (1)
- Chemicals (1)
- Electronic & Electrical Equipment (1)
- Food Producers & Processors (1)
- General Retailers (1)
- Other Financial (1)
- Other Health Care (1)
11 April 2014In the first 10-company segment of our analysis of Aim's top 100 companies, we give our verdict on Silence, Providence, Unitech, Sinclair, Accesso,...
11 April 2014In the second 10-company segment of our analysis of Aim's top 100 companies, we give our verdict on Asian Citrus, Stanley Gibbons, FW Thorpe,...
01 April 2014RESULTS: Aim-listed drug company Vernalis is hoping to create a lucrative revenue stream from prescription cold medication - that could gain US regulatory...
31 March 2014RESULTS: Developer of inhalation products Skyepharma (SKP) has exceeded market expectations with a profitable turn in 2013
31 March 2014RESULTS: Condom developer Futura Medical (FUM) is excited to see the launch of several products over the next 12 months.
28 March 2014The NASDAQ biotechnology index took a big hit last week. But is the spending spree on life sciences IPOs over?
26 March 2014RESULTS: Personal medicine and diagnositics group Epistem Holdings (EPH) is trying to recover from the loss of a major distribution partner
24 March 2014Interim results from Allergy Therapeutics (AGY) reveal strong trading amid the rapid rise in the share price.